Fate Therapeutics Inc (FATE)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

12,957,222 $290,371 11.26%
2.
ARK Investment Management

Catherine D. Wood

11,655,833 $261,207 +2% 1.82%
3.
Casdin Capital

Eli Casdin

2,050,000 $45,941 -3% 3.01%
4. 1,311,113 $29,382 -36% 1.34%
5.
Millennium Management

Israel Englander

640,724 $14,359 -13% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$85.50 327,485 Large Shareholder, Director 12,957,222 2021-01-08 Filing
$28.31 1,412,928 Large Shareholder, Director 12,629,737 2020-06-11 Filing
$17.50 857,143 Large Shareholder, Director 11,216,809 2019-09-16 Filing
$13.50 3,703,704 Large Shareholder, Director 10,359,666 2018-09-25 Filing
$2.66 37,593 Officer 37,593 2016-11-23 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$30.41 432 Officer 136,801 2022-08-18 Filing
$29.75 4,703 Officer 137,233 2022-08-18 Filing
$33.28 620 Officer, Director 431,546 2022-07-22 Filing
$32.61 2,703 Officer, Director 432,166 2022-07-22 Filing
$31.33 2,923 Officer, Director 434,869 2022-07-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 410,893 $9,208,111 0%
2. 267,178 $5,987,459 0%
3. 44,394 $994,870 0.01%
4. 8,231,312 $184,464 0.04%
5. 7,917,421 $177,428 0%
News See All